Targeting chromatin in fungal pathogens as a novel therapeutic strategy: histone modification gets infectious

Pathogenesis of invasive candidiasis

(2010) Frank L van de Veerdonk et al.   Current Opinion in Critical Care

The Chromatin Signaling Pathway: Diverse Mechanisms of Recruitment of Histone-Modifying Enzymes and Varied Biological Outcomes

(2010) Edwin Smith et al.   MOLECULAR CELL

Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy

(2010) Hugo Wurtele et al.   NATURE MEDICINE

Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis

(2010) J. Lopes da Rosa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Set3/Hos2 Histone Deacetylase Complex Attenuates cAMP/PKA Signaling to Regulate Morphogenesis and Virulence of Candida albicans

(2010) Denes Hnisz et al.   PLoS Pathogens

Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei-Infected Mice

(2009) S. Agbor-Enoh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching inCandida albicans

(2009) Denes Hnisz et al.   MOLECULAR MICROBIOLOGY

The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans

(2009) Gerben Ferwerda et al.   VACCINE

The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype

(2008) Leah E. Cowen   NATURE REVIEWS MICROBIOLOGY